`Filed: December 18, 2019
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`AMNEAL PHARMACEUTICALS LLC,
`Petitioner,
`
`v.
`
`CUBIST PHARMACEUTICALS LLC,
`Patent Owner.
`
`________________
`
`Case IPR2020-00193
`Patent 9,138,456
`________________
`
`POWER OF ATTORNEY PURSUANT TO 37 C.F.R. § 42.10(b)
`
`
`
`
`
`
`
`Patent Owner and real party-in-interest Cubist Pharmaceuticals LLC and real
`
`parties-in-interest Merck & Co., Inc. and Merck Sharpe & Dohme Corp. hereby
`
`appoint Raymond N. Nimrod (Reg. No. 31,987) of Quinn Emanuel Urquhart &
`
`Sullivan, LLP as lead counsel and Matthew A. Traupman (Reg. No. 50,832),
`
`Amanda K. Antons (Reg. No. 65,236), and Allyson E. Parks (Reg. No. 73,335) of
`
`Quinn Emanuel Urquhart & Sullivan, LLP to prosecute Inter Partes Review No.
`
`1PR2020-00193, conceming US. Patent No. 9,138,456 before the Patent Trial and
`
`Appeal Board in the United States Patent and Trademark Office, and to transact all
`
`business connected therewith.
`
`The undersigned is authorized to sign this Power of Attorney on behalf of
`
`Patent Owner and real party-in-interest Cubist Pharmaceuticals LLC and real
`
`parties-in-interest Merck & Co., Inc. and Merck Sharpe & Dohme Corp.
`
`Date:
`
`12/17/2019
`
`For: Cubist Pharmaceuticals LLC, Merck & Co.,
`Inc., and Merck Sharpe & Dohme Corp.
`
`Signature: M/ mH
`
`
`
`
`Print Name: Gerard M. Devlin Jr.
`
`Title:
`
`Managing Counsel
`
`